Logo image of NVG

NUVEEN AMT-FR MUNI CRDT (NVG) Stock Price, Quote, News and Overview

NYSE:NVG - New York Stock Exchange, Inc. - US67071L1061 - Currency: USD

12.58  -0.18 (-1.41%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
NVG revenue by date.NVG revenue by date.
231.7M
-5.47%
226.2M
-2.37%
222.349M
-1.70%
EBITDA
YoY % growth
NVG ebitda by date.NVG ebitda by date.
N/AN/AN/A
EBIT
YoY % growth
NVG ebit by date.NVG ebit by date.
175.1M
0.06%
156.4M
-10.68%
113.267M
-27.58%
Operating Margin
NVG operating margin by date.NVG operating margin by date.
75.57%69.14%50.94%
EPS
YoY % growth
NVG eps by date.NVG eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
NVG Yearly EPS VS EstimatesNVG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
111.539M
-0.68%
%
Q2 2023
Q2Q % growth
110.8M
-2.72%
%
Q4 2022
Q2Q % growth
112.3M
-1.49%
%
Q2 2022
Q2Q % growth
113.9M
-3.23%
%
Q4 2021
Q2Q % growth
114M
-6.48%
%
Q2 2021
Q2Q % growth
117.7M
-4.54%
%
Q4 2020
Q2Q % growth
121.9M %
Q2 2020
Q2Q % growth
123.3M
1.73%
%
NVG Yearly Revenue VS EstimatesNVG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A